- Price is above Fair Value, showing premium demand versus the model.
- Next-week expectancy is positive at 55.64% based on similar historical setup states.
- Activity pressure is constructive, supporting the smart-money activity read.
NARMADA
NSI
Week ended 07 Aug 2026
Weekly Investor Report
Narmada Agrobase Limited · Basic Materials · Agricultural Inputs
Latest close
13.89 INR
-18.4%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -18.4% below the Trend Line and sits at 31.2% of its 52-week range. The latest completed week returned -18.4%, after a -20.1% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 54/100.
Setup score
33
out of 100
Latest Close
13.89 INR
7 Aug 2026
1W Return
-18.4%
latest completed week
4W Return
-20.1%
short-term follow-through
12W Return
-22.0%
quarterly tape
Trend Breadth
94.2%
49 of 52 weeks active
Volume Ratio
1.3x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Activity pressure is negative, which weakens the current setup.
- 4 reversal markers appear in the recent smart-money tape.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-18.4%
Latest completed week; four-week move -20.1%.
Indicator stack
52/0
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Positive 55.64%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
54/100
21 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -18.4% below the Trend Line and sits at 31.2% of its 52-week range. The latest completed week returned -18.4%, after a -20.1% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.3x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.6812-week average 0.90
12-week confirmation
Trend active11/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure7/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership11/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.68Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers44 reversal markers
No recent accumulation markers. 4 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -20.1% over four weeks, -22.0% over 12 weeks, and 19.3% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year49
Trend breadth94.2%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.86Latest activity-pressure read.
Pressure change-1624.1%Four-week change in activity pressure.
Leadership-5.48Latest relative-leadership reading.
RS change-122.6%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 88%
Model confidence 82%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength50/100Blend of value, momentum, and quality. Underlying universe rank 51; rank 1 is best.
Value50/100Relative valuation strength. Underlying universe rank 51; rank 1 is best.
Quality49/100Profitability and accounting quality. Underlying universe rank 52; rank 1 is best.
Momentum51/100Medium-term price momentum. Underlying universe rank 50; rank 1 is best.
Growth49/100Revenue and earnings growth. Underlying universe rank 52; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework35/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 27.3x Price divided by trailing earnings.
- Price / sales
- 1.3x Market value relative to trailing revenue.
- EV / EBITDA
- 18.5x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- -1.3% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 12.9% Gross profit retained from each unit of revenue.
- Operating margin
- 6.1% Operating profit retained from revenue.
- Free-cash-flow margin
- -1.8% Free cash flow generated from revenue.
- Return on invested capital
- 5.1% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 19.4% Latest one-year revenue growth.
- EPS growth
- -5.6% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 4/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- 0.0% Net share repurchases relative to market value.
- Shareholder yield
- 0.0% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 1.6x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment54/100
Weighted news tone is neutral across 21 relevant articles.
6 positive · 13 neutral · 2 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-38.5%Distance below the 52-week high.
13-week volatility10.0%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher10 of 2616 weeks finished lower.
Best week+19.9%Week of 26 Jun.
Worst week-18.4%Week of 7 Aug.
Latest week-18.4%Week of 7 Aug.
Shape of recent returns
Strong gains6
Modest gains4
Flat weeks0
Modest losses12
Sharp losses4
Recent vol10.0%13-week weekly-return volatility.
Base vol7.1%52-week weekly-return volatility.
Up/down split23/29Count of positive and negative weeks in the 52-week window.
Average skew6.7% / -4.2%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIN Basic Materials
4-week rank- / 100
Group average2.8%
Trend breadth52.0%
Trend52.0%active weekly trend signals
MD52.0%positive activity pressure
RS63.0%positive relative leadership
Four-week leaders
IndustryIN Agricultural Inputs
4-week rank46 / 47
Group average0.9%
Trend breadth19.1%
Trend19.1%active weekly trend signals
MD36.2%positive activity pressure
RS14.9%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape39/100
Trend, activity pressure, participation, and risk combine to a 39/100 tape read.
Indicator analysis65/100Latest 12-week confirmation: trend 11/12, activity pressure 7/12, relative leadership 11/12.
Activity pressure 0.68; 4 reversal markers Next-Week ExpectancyPositive 55.64%Next-week expectancy is positive with a 55.64% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors49/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 15 SVQF35/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 1026.5 of 1576 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment54/100Weighted news tone is neutral across 21 relevant articles.
Narmada Agrobase sets July 31 record date for share sub-division Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 13.89 INR | -18.4% | 17.03 INR | 10.66 INR | -0.86 | -5.48 | 19.7M | Off |
| 31 Jul 2026 | 17.02 INR | -2.5% | 17.00 INR | 10.61 INR | -0.83 | 17.04 | 32.8M | On |
| 24 Jul 2026 | 17.46 INR | -10.9% | 16.81 INR | 10.56 INR | -0.61 | 24.33 | 10.3M | On |
| 17 Jul 2026 | 19.59 INR | 12.7% | 16.58 INR | 10.49 INR | -0.05 | 37.54 | 19.7M | On |
| 10 Jul 2026 | 17.39 INR | -4.3% | 16.28 INR | 10.42 INR | -0.05 | 24.28 | 4.4M | On |
| 3 Jul 2026 | 18.17 INR | -15.0% | 16.04 INR | 10.35 INR | 0.43 | 31.14 | 27.2M | On |
| 26 Jun 2026 | 21.36 INR | 19.9% | 15.81 INR | 10.29 INR | 0.55 | 57.69 | 22.6M | On |
| 19 Jun 2026 | 17.82 INR | -3.8% | 15.49 INR | 10.20 INR | 0.38 | 34.19 | 6.7M | On |
| 12 Jun 2026 | 18.52 INR | -1.8% | 15.30 INR | 10.13 INR | 0.61 | 43.88 | 37.2M | On |
| 5 Jun 2026 | 18.86 INR | 1.3% | 15.05 INR | 10.06 INR | 0.47 | 50.48 | 2.7M | On |
| 29 May 2026 | 18.61 INR | -1.0% | 14.80 INR | 9.99 INR | 0.57 | 49.79 | 2.9M | On |
| 22 May 2026 | 18.80 INR | 5.6% | 14.57 INR | 9.92 INR | 0.47 | 52.68 | 5.0M | On |
| 15 May 2026 | 17.80 INR | -3.8% | 14.34 INR | 9.85 INR | 0.38 | 47.52 | 3.9M | On |
| 8 May 2026 | 18.51 INR | 9.3% | 14.15 INR | 9.79 INR | 0.58 | 52.26 | 5.9M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.